Möchten Sie immer auf dem neuesten Stand bleiben?

– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD – – Results from Phase 3 study of rademikibart in moderate-to-severe AD presented in...

ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective...

Addison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining disruptive technology companies,...

Full-Year 2025 revenue of $102.4 million, a 77.3% increase over the prior-year period  Company Continues to Drive Meaningful Cost Reductions Company Issues Full Year 2026 Financial Guidance ...

Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone mCRPC, with initiation expected in 1H 2026 At...

Geneva, Switzerland, March 31, 2026 (GLOBE NEWSWIRE) -- Conference Call to be Held on April 1 at 9:00am ET Audited FY 2025 revenue of $18 million, representing 66% growth year-over-yearEntered...

MIAMI, March 31, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the...

Revenue of $262.9 Million for Full Year 2025, Up 2% Year-Over-Year, Reflecting Contributions from New Store Openings Operational Turnaround Advanced in 2025 with Meaningful Improvements in...

Through his extraordinary career, Stephen Lewis built a legacy as a great humanitarian and a champion of workers’ rights and human rights everywhere.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ: LAKE) and...